AlphAIAlphAI — Financial news for AI agents
tradingview.comOCT 271 min read$FSLR

Guggenheim maintains Buy rating on First Solar, $299 price target

Guggenheim kept a Buy rating on First Solar with a $299 price target, implying a 77.8% upside from the Oct 26 close. The firm cited First Solar's manufacturing commitment in Southeast Asia and anticipated pricing upside due to regulatory changes.

Original reporting
tradingview.com
Published Oct 27, 2026, 1:27 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 1:31 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Guggenheim maintains Buy rating on First Solar, $299 price target — source image
Source · tradingview.com
Decision brief

The 30-second read

$FSLRBullishMed
01

Why it matters

The rating maintenance and higher target could attract new buying interest.

02

Market read

A fresh, higher price target from a reputable analyst may drive short‑term buying pressure.

03

What to watch

Supply‑chain constraints in Southeast Asia could temper upside.

Relevance 6/10Novelty 6/10Timing: immediate

Background

First Solar is a leading thin‑film photovoltaic manufacturer; analyst coverage influences its valuation.

Company-level read

Ticker impact

$FSLRBullishMedium confidence
Context

Guggenheim maintained a Buy rating on First Solar and raised its price target to $299, implying a 77.8% upside.

Expected impact

likely upward pressure as investors price in the new target

Evidence & confidence

The fresh price target provides a concrete upside thesis that can move the stock in the short term.

Market effects

Sector

May lift sentiment for the solar and renewable energy sector.

Regional

Potentially supportive for U.S. clean‑energy equities.

Global

Limited to investors tracking solar equipment makers.

Counterpoint

What could challenge this read

Some investors may view the target as overly optimistic given pricing headwinds.

Key entities

  • Analyst Firm
    Guggenheim

    Equity research house issuing the rating.

  • Company
    First Solar

    Solar panel manufacturer.

Read at source← All news

Related articles

OCT 13
$FSLRMed

First Solar Climbs 4% as Truist Buy Call and December Tariff Floor Reset Panel Pricing Outlook; Enphase Energy and Sunrun Hold Flat

First Solar (FSLR) stock rose 4% to $186.21 after a Truist upgrade to Buy with a $270 price target, citing improved pricing and valuation. The U.S. Department of Commerce's Section 232 trade decision sets a minimum import price for foreign solar panels, benefiting First Solar. Enphase (ENPH) and Sunrun (RUN) stocks remained flat. First Solar's thin-film technology and U.S. manufacturing position it favorably against competitors.

247wallst.com7 min
OCT 12
$FSLRHigh

Why First Solar (FSLR) Stock Is Up Today

First Solar (FSLR) stock rose 1.8% after Truist Securities upgraded it to Buy with a $229 price target, citing improved pricing and demand forecasts. Shares later cooled to $180.10, up 1.3%. The upgrade follows a 32% YTD decline, with the analyst noting strong domestic demand and anti-stockpiling restrictions benefiting the company.

financialcontent.com2 min
OCT 12
$FSLRHigh

Truist upgrades First Solar stock rating on stronger pricing outlook

Truist upgraded First Solar (FSLR) to Buy, raising its price target to $270 from $229. The upgrade is based on stronger pricing outlook and valuation reset, with a 17% increase in 2029 U.S. module ASP estimates. Truist forecasts strong U.S. solar installations and cites regulatory support. Other analysts have also upgraded FSLR, citing undervaluation and potential earnings drivers.

investing.com2 min
OCT 12
$FSLRHigh

Why is First Solar stock up over 2% today?

First Solar (FSLR) stock rose 2.4% in pre-market trading after Truist Securities upgraded it to 'Buy' and raised its price target to $270, citing favorable pricing and regulatory conditions. The stock is still below its 52-week high of $320.95. Analysts have largely positive ratings, with 26 Buys, 9 Holds, and 1 Sell. The broader market is mixed ahead of bank earnings season.

investing.com1 min